Home/Filings/4/0001209191-18-047607
4//SEC Filing

Smith Patton Paul 4

Accession 0001209191-18-047607

CIK 0001108109other

Filed

Aug 19, 8:00 PM ET

Accepted

Aug 20, 4:13 PM ET

Size

12.5 KB

Accession

0001209191-18-047607

Insider Transaction Report

Form 4
Period: 2018-08-20
Smith Patton Paul
Division President
Transactions
  • Purchase

    Common Stock

    2018-08-20$3.51/sh+10,000$35,130103,417 total
Holdings
  • Stock Options (Right to Buy)

    Exercise: $17.49From: 2013-02-16Exp: 2022-02-15Common Stock (1,000 underlying)
    1,000
  • Performance Based Restricted

    Exercise: $0.00From: 2021-03-01Exp: 2028-02-28Common Stock (30,000 underlying)
    30,000
  • Stock Options (Right to Buy)

    Exercise: $34.38From: 2012-02-23Exp: 2021-02-22Common Stock (1,000 underlying)
    1,000
  • Stock Options (Right to Buy)

    Exercise: $30.32From: 2011-02-24Exp: 2020-02-23Common Stock (1,000 underlying)
    1,000
  • Performance Based Restricted

    Exercise: $0.00From: 2020-03-01Exp: 2027-02-28Common Stock (20,000 underlying)
    20,000
Footnotes (3)
  • [F1]These shares were purchased in a series of transactions at a weighted average purchase price of approximately $3.513 per share.
  • [F2]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between January 1, 2017 and December 31, 2019 (the "2017-2019 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the target number of performance-based restricted shares subject to the attainment of the applicable performance objectives will ultimately vest on the third anniversary of the date of grant, with the vesting percentage to be determined based upon achievement with respect to the applicable criteria during the 2017-2019 Performance Period.
  • [F3]The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between January 1, 2018 and December 31, 2020 (the "2018-2020 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the target number of performance-based restricted shares subject to the attainment of the applicable performance measures will ultimately vest on the third anniversary of the date of grant, with the vesting percentage to be determined based upon achievement with respect to the applicable criteria during the 2018-2020 Performance Period.

Issuer

COMMUNITY HEALTH SYSTEMS INC

CIK 0001108109

Entity typeother

Related Parties

1
  • filerCIK 0001665775

Filing Metadata

Form type
4
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 4:13 PM ET
Size
12.5 KB